Geron Corp (GERN) stock
GERNNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.91−0.08 (-7.86%)
Close on Nov 19, 2026Market cap $586.58MP/E –Yield –
Geron net income
Net income is the profit left for shareholders after every expense, interest and tax.
Geron's net income for the twelve months ending Jun 30, 2026 was -$67.61M. For fiscal 2025 it was -$83.50M. The highest annual figure on record is $46.00K in fiscal 2015.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$83.50M | – |
| FY2024 | Dec 31, 2024 | -$174.57M | – |
| FY2023 | Dec 31, 2023 | -$184.13M | – |
| FY2022 | Dec 31, 2022 | -$141.90M | – |
| FY2021 | Dec 31, 2021 | -$116.11M | – |
| FY2020 | Dec 31, 2020 | -$75.62M | – |
| FY2019 | Dec 31, 2019 | -$68.55M | – |
| FY2018 | Dec 31, 2018 | -$27.02M | – |
| FY2017 | Dec 31, 2017 | -$27.92M | – |
| FY2016 | Dec 31, 2016 | -$29.54M | -64310.9% |
| FY2015 | Dec 31, 2015 | $46.00K | – |
| FY2014 | Dec 31, 2014 | -$35.67M | – |
| FY2013 | Dec 31, 2013 | -$38.38M | – |
| FY2012 | Dec 31, 2012 | -$68.88M | – |
| FY2011 | Dec 31, 2011 | -$96.85M | – |
| FY2010 | Dec 31, 2010 | -$111.38M | – |
| FY2009 | Dec 31, 2009 | -$70.18M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$16.68M | – |
| Q1 FY2026 | Mar 31, 2026 | -$3.64M | – |
| Q4 FY2025 | Dec 31, 2025 | -$28.86M | – |
| Q3 FY2025 | Sep 30, 2025 | -$18.43M | – |
| Q2 FY2025 | Jun 30, 2025 | -$16.38M | – |
| Q1 FY2025 | Mar 31, 2025 | -$19.84M | – |
| Q4 FY2024 | Dec 31, 2024 | -$25.35M | – |
| Q3 FY2024 | Sep 30, 2024 | -$26.45M | – |
| Q2 FY2024 | Jun 30, 2024 | -$67.38M | – |
| Q1 FY2024 | Mar 31, 2024 | -$55.39M | – |
| Q4 FY2023 | Dec 31, 2023 | -$51.97M | – |
| Q3 FY2023 | Sep 30, 2023 | -$44.81M | – |
| Q2 FY2023 | Jun 30, 2023 | -$49.23M | – |
| Q1 FY2023 | Mar 31, 2023 | -$38.12M | – |
| Q4 FY2022 | Dec 31, 2022 | -$42.64M | – |
| Q3 FY2022 | Sep 30, 2022 | -$41.05M | – |
| Q2 FY2022 | Jun 30, 2022 | -$28.12M | – |
| Q1 FY2022 | Mar 31, 2022 | -$30.10M | – |
| Q4 FY2021 | Dec 31, 2021 | -$32.02M | – |
| Q3 FY2021 | Sep 30, 2021 | -$26.70M | – |
| Q2 FY2021 | Jun 30, 2021 | -$29.57M | – |
| Q1 FY2021 | Mar 31, 2021 | -$27.82M | – |
| Q4 FY2020 | Dec 31, 2020 | -$23.79M | – |
| Q3 FY2020 | Sep 30, 2020 | -$19.65M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.82M | – |
| Q1 FY2020 | Mar 31, 2020 | -$16.36M | – |
| Q4 FY2019 | Dec 31, 2019 | -$29.07M | – |
| Q3 FY2019 | Sep 30, 2019 | -$15.18M | – |
| Q2 FY2019 | Jun 30, 2019 | -$14.24M | – |
| Q1 FY2019 | Mar 31, 2019 | -$10.06M | – |
| Q4 FY2018 | Dec 31, 2018 | -$7.30M | – |
| Q3 FY2018 | Sep 30, 2018 | -$5.60M | – |
| Q2 FY2018 | Jun 30, 2018 | -$6.93M | – |
| Q1 FY2018 | Mar 31, 2018 | -$7.19M | – |
| Q4 FY2017 | Dec 31, 2017 | -$7.43M | – |
| Q3 FY2017 | Sep 30, 2017 | -$6.90M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.41M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.18M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.48M | – |
| Q3 FY2016 | Sep 30, 2016 | -$3.58M | – |
See a number that looks wrong?